NVOS (Novo Integrated Sciences) Ending Cash Position: $1.54 Mil (As of May. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences Ending Cash Position?

Novo Integrated Sciences NVOS 12 Ending Cash Position is $1.54 Mil as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

Novo Integrated Sciences's Ending Cash Position for the quarter that ended in May. 2024 was $1.54 Mil.

Novo Integrated Sciences's quarterly Ending Cash Position declined from Nov. 2023 ($1.64 Mil) to Feb. 2024 ($0.65 Mil) but then increased from Feb. 2024 ($0.65 Mil) to May. 2024 ($1.54 Mil).

Novo Integrated Sciences's annual Ending Cash Position declined from Aug. 2021 ($8.29 Mil) to Aug. 2022 ($2.18 Mil) and declined from Aug. 2022 ($2.18 Mil) to Aug. 2023 ($0.42 Mil).

Novo Integrated Sciences Ending Cash Position Related Terms

Novo Integrated Sciences Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences Ending Cash Position Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.08 2.07 8.29 2.18 0.42

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.46 0.42 1.64 0.65 1.54
NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Novo Integrated Sciences's Ending Cash Position for the fiscal year that ended in Aug. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=2.178+-1.762
=0.42

Novo Integrated Sciences's Ending Cash Position for the quarter that ended in May. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.65+0.89
=1.54

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $1.54 Mil mean?
Novo Integrated Sciences (NVOS) has a Ending Cash Position of $1.54 Mil as of May. 2024. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' Ending Cash Position too high?
Novo Integrated Sciences' current Ending Cash Position is $1.54 Mil. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' Ending Cash Position compare to BACK and NHLG?
Novo Integrated Sciences' Ending Cash Position of $1.54 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Novo Integrated Sciences and its competitors. Novo Integrated Sciences's current Ending Cash Position is $1.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current Ending Cash Position of $1.54 Mil. The current Ending Cash Position is $1.54 Mil. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current Ending Cash Position is $1.54 Mil as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price